Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 22:10:1884.
doi: 10.3389/fimmu.2019.01884. eCollection 2019.

The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer

Affiliations
Review

The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer

Asaf Maoz et al. Front Immunol. .

Abstract

The Crohn's-like lymphoid reaction (CLR) to colorectal cancer (CRC), a CRC-specific ectopic lymphoid reaction, is thought to play an important role in the host response to CRC. CLR is characterized by peritumoral lymphocytic aggregates that are found at the advancing edge of the tumor. Spatial and molecular characterization of CLR within the tumor microenvironment (TME) have uncovered a spectrum of peritumoral lymphoid aggregates with varying levels of organization and maturation. In early stages of CLR development, CD4+ T-cells cluster predominantly with mature antigen presenting dendritic cells. As CLR matures, increasing numbers of B-cells, as well as follicular dendritic cells are recruited to create lymphoid follicles. When highly organized, CLR resembles functional tertiary lymphoid structures (TLS), allowing for lymphocyte recruitment to the TME and promoting a tumor-specific adaptive immune response. CLR has been consistently associated with favorable prognostic factors and improved survival among CRC patients, often providing more prognostic information than current clinical staging systems. However, consensus is lacking regarding CLR scoring and it is not clinically assessed or reported. Differences between CLR and other cancer-associated lymphoid structures exist both in primary and metastatic disease, underscoring the need to characterize organ-specific TLS. Further research is needed to explore the role of CLR in predicting response to immunotherapy and to leverage CLR to promote immunotherapeutic strategies in CRC.

Keywords: adaptive immune response; colorectal cancer; crohn's-like lymphoid reaction; ectopic lymphoid structure; microsatellite instability (MSI); tertiary lymphoid organs; tertiary lymphoid structures (TLS); tumor immunology and microenvironment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histopathological view of the Crohn's-like lymphoid Reaction. (A–D) demonstrate the variable pathologic appearance of the Crohn's-like lymphoid reaction.
Figure 2
Figure 2
Documented maturation stages of the CLR. (A) Clusters of mature CD83+ DCs with predominantly CD4+ T-cells; (B) Dense lymphocytic aggregates form without FDCs; (C) Primary follicle-like TLS, with an increasing abundance of B cells and FDCs, but no germinal center reaction; (D) Secondary follicle-like TLS, having active germinal centers. TLS, tertiary lymphoid structure; DC, dendritic cell; FDC, follicular dendritic cell.

Similar articles

Cited by

References

    1. Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, Resnick MB, et al. . Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol. (2003) 27:563–70. 10.1097/00000478-200305000-00001 - DOI - PubMed
    1. Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, et al. . Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. (2009) 33:126–33. 10.1097/PAS.0b013e31817ec2b1 - DOI - PMC - PubMed
    1. Rozek LS, Schmit SL, Greenson JK, Tomsho LP, Rennert HS, Rennert G, et al. Tumor-infiltrating lymphocytes, crohn's-like lymphoid reaction, and survival from colorectal cancer. J Natl Cancer Inst. (2016) 12:108 10.1093/jnci/djw027 - DOI - PMC - PubMed
    1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. (2006) 313:1960–4. 10.1126/science.1129139 - DOI - PubMed
    1. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. . Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. (2011) 29:610–8. 10.1200/JCO.2010.30.5425 - DOI - PubMed